Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
Hand-out
Press Releases
February 24, 2025

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

TORONTO and AACHEN, Germany, Feb. 24, 2025 /PRNewswire/ - Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management and related diseases, announced today

bradford

The Bradford Era

Local & Social